Skip to site content

CRS 2018 (v18.0)

CRS VERSION 18.0

CRS Version 18.0 was released on December 4, 2017.

View the CRS 2018 (v18.0) National GPRA/GPRAMA Report Performance Measure List and Definitions [PDF - 520 KB]

View the CRS 2018 (v18.0) National GPRA Developmental Report Performance Measure List and Definitions [PDF - 335 KB]

Key enhancements included in CRS Version 18.0 are shown below.

  • Changed GPRA year to October 1 through September 30
  • Logic Changes to National GPRA/GPRAMA Report Measures
    • GPRA Developmental Measures:
      • Added the following new GPRA Developmental measures:
        • Access to Dental Service (patients with a dental visit – new logic)
        • Cancer Screening: Pap Smear Rates (Pap Smear and HPV must be on the same day)
        • Cancer Screening: Mammogram Rates (ages 52-74)
        • Tobacco Cessation (new logic for denominator that only looks at health factors)
        • Chlamydia Testing: (new age breakdown of 21-24; new measures to match HEDIS measures for patients identified as sexually active)
        • Concurrent Use of Opioids and Benzodiazepines (new topic)
      • Removed measures:
        • Adult IZ measures moved to GPRA report
      • Updated codes and/or logic in the following measures: Access to Dental Service; Dental Sealants; Topical Fluoride; Adult Immunizations; Childhood Immunizations; Colorectal Cancer Screening (changed logic to match HEDIS definition); Comprehensive Cancer Screening; Weight Assessment and Counseling for Nutrition and Physical Activity; HIV Screening; Sexually Transmitted Infection (STI) Screening; Visit Statistics
    • Diabetes: Glycemic Control: Changed GPRA measure to User Pop Diabetic Patients denominator.
    • Diabetes: Blood Pressure Control: Changed GPRA measure to User Pop Diabetic Patients denominator.
    • Statin Therapy to Reduce Cardiovascular Disease Risk in Patients with Diabetes: (1) Changed GPRA measure to User Pop Diabetic Patients denominator. (2) Added new pregnancy codes. (3) Included outside statin medications. (4) Added "Nystatin" as an exception to adverse reaction to statins in Allergy Tracking file and Patient List. (5) Updated BGP PQA STATIN MEDS medication taxonomy.
    • Diabetes: Nephropathy Assessment: Changed GPRA measure to User Pop Diabetic Patients denominator.
    • Diabetic Retinopathy: Changed GPRA measure to User Pop Diabetic Patients denominator.
    • Dental Sealants: Removed restriction on 0007 code that it cannot be documented on the same visit as other codes.
    • Influenza: (1) Changed GPRA measure to User Population denominator. (2) Added CVX codes 168, 185, 186 and CPT codes 90653, 90682. (3) Removed Egg Allergy as a contraindication.
    • Adult Immunizations: (1) Changed GPRA measure to User Population 19 and older with age-appropriate immunizations. (2) Split pneumococcal definition into Pneumococcal Polysaccharide (PPSV23) and Pneumococcal Conjugate (PCV13). (3) Removed POV code V06.6 from Pneumococcal definition. (4) Updated definition of "up-to-date" Pneumococcal Polysaccharide vaccine (PPSV23)/Pneumo conjugate (PCV13): Patients who received A) a dose of PCV13 on or after age 19 years OR who received a dose of PPSV23 in the past year AND B) a dose of PPSV23 on or after age 65 years OR a dose of PPSV23 in the past 5 years OR who received a dose of PCV13 in the past year. (5) Moved measures for separate age groups and immunizations including combo measures from GPRA Dev report and added corresponding logic. (6) Added new measures that look for PPSV23 and PCV13, including combo measures. (7) Removed contraindication/NMI refusal sub-numerators.
    • Childhood Immunizations: (1) Changed GPRA measure to User Population denominator. (2) Added CVX code 148 and CPT code 90644 to Hib (4-dose) definition. (3) Added Encephalopathy due to vaccination with vaccine adverse-effect to DTaP contraindication definition. (4) Added Immunodeficiency, HIV, and Lymphoreticular cancer, multiple myeloma or leukemia to MMR and varicella contraindication definitions.
    • Cancer Screening: Pap Smear Rates: (1) Changed GPRA measure to User Population denominator. (2) Replaced codes 0UT9*ZZ with 0UTC*ZZ in hysterectomy definition. (3) Added HCPCS code G0476 to HPV definition.
    • Cancer Screening: Mammogram Rates: Changed GPRA measure to User Population denominator.
    • Colorectal Cancer Screening: (1) Changed GPRA measure to User Population denominator. (2) Added POV codes ICD-9: V10.06 and ICD-10: C21.2, C21.8, Z85.048 to colorectal cancer definition. (3) Added CPT codes 45346, 45347, 45349, 45350 to flexible sigmoidoscopy definition. (4) Added CPT codes 44401-44408, 45388-45390, 45393, 45398 to colonoscopy definition.
    • Tobacco Cessation: (1) Changed GPRA measure to User Population denominator. (2) Added Tobacco: Electronic Nicotine Delivery Systems (ENDS) health factors (Current ENDS user and Cessation ENDS user) to Tobacco User/User in Cessation definition. (3) Added Previous (former) ENDS user to Quit Tobacco Use definition. (4) Updated tobacco cessation counseling definition to include patient education codes containing SNOMED codes in data set PXRM BPG TOBACCO TOPICS.
    • Alcohol Screening: (1) Changed GPRA measure to User Population denominator. (2) Changed age range to 9-75. (3) Removed measures for age 12-75.
    • Screening, Brief Intervention, and Referral to Treatment (SBIRT): Changed GPRA measure to User Population denominator.
    • Intimate Partner (Domestic) Violence Screening: Changed GPRA measure to User Population denominator.
    • Depression Screening: (1) Changed GPRAMA and GPRA measures to User Population denominator. (2) Added new POV codes ICD-9: 290.13, 290.21, 290.43, 298.0, 301.12, 309.0, 309.1, 309.28; ICD-10: F01.51, F31.74, F32.89, F34.81, F34.89, F43.21, F43.23 to mood disorder definition.
    • Antidepressant Medication Management: (1) Updated the number of gap days from 30 to 31 for Effective Acute Phase treatment measure. (2) Excluded outside medications and e-prescribed medications from these measures. (3) Clarified that inpatient, outpatient, ED, intensive outpatient or partial hospitalization setting is defined as Service Categories A and H. (4) Fixed logic errors.
    • Childhood Weight Control: Changed GPRA measure to User Population denominator.
    • Controlling High Blood Pressure - Million Hearts: Added new pregnancy codes.
    • Statin Therapy for the Prevention and Treatment of Cardiovascular Disease: (1) Added new pregnancy codes. (2) Included outside statin medications. (3) Added "Nystatin" as an exception to adverse reaction to statins in Allergy Tracking file and Patient List. (4) Updated BGP PQA STATIN MEDS medication taxonomy.
    • HIV Screening: (1) Added CPT codes 87389 and 87806 to HIV screening definition. (2) Added new pregnancy codes.
    • Breastfeeding Rates: Changed GPRA measure to User Population denominator.

CRS 2018 DOCUMENTATION

CRS 2018 (v18.0) User Manual [PDF - 4.9 MB]

Visual CRS 2018 (v18.0) User Manual [PDF - 5.8 MB]

CRS 2018 (v18.0) Installation Guide [PDF - 367 KB]

CRS 2018 (v18.0) Technical Manual [PDF - 876 KB]

CRS 2018 (v18.0) National GPRA/GPRAMA Report Performance Measure List and Definitions [PDF - 520 KB]

CRS 2018 (v18.0) National GPRA Developmental Report Performance Measure List and Definitions [PDF - 355 KB]

CRS 2018 (v18.0) Selected Measures Report Performance Measure List and Definitions [PDF - 949 KB]

CRS 2018 (v18.0) Other National Measures Report Performance Measure List and Definitions [PDF - 390 KB]

CRS 2018 (v18.0) Elder Care Report Performance Measure List and Definitions [PDF - 255 KB]

CRS 2018 (v18.0) Patient Education Report Performance Measure List and Definitions [PDF - 88 KB]